Atlas Trials

Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer

Clinical trial NCT03843229 · UNKNOWN

Trial details

NCT number
NCT03843229
Sponsor
The First Affiliated Hospital of Dalian Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Liver Cancer
Start date
2019-01-27
Primary completion
2020-09-01
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.